Metabolic dysfunction presented as hyperinsulinemia, insulin resistance assessed by HOMA‐IR, decreased hepatic insulin extraction, and hyperglucagonemia as sign of glucagon resistance. The gene discussed is INS; the disease is hyperinsulinism.